Thousand Oaks, CA, United States of America

Michael J Frohn

This inventor holds 37 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in Cancer Therapeutics. Top assignee: Amgen Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Frohn. Retrieved from https://idiyas.com/inventor/michael-j-frohn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 9)

% Patents Active = 94.6

CIPO Patents = 4 (Patent Applications = 9)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 11.2

ph-index = 6

Forward Citations = 140(Granted Patents)

Company Filing History:

37 out of 2,072

Amgen Inc.

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

KRAS G12C Inhibitors

Beta-Secretase Inhibitors

PDE10 Inhibitors

Prolyl Hydroxylase Inhibitors

Apelin Polypeptides

Heterocyclic Compounds

Azetidine Compounds

Cyclopropyl Fused Compounds

Carbohydrate Phosphonates

Quinolone Compounds

Naphthalenone Compounds

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679868 - Apelin polypeptides (2026-07-14),

2. 12540129 - KIF18A inhibitors (2026-02-03),

3. 12509442 - KIF18A inhibitors (2025-12-30),

4. 12459932 - KIF18A inhibitors (2025-11-04),

5. 12441736 - KIF18A inhibitors (2025-10-14),

6. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

7. 12054476 - KIF18A inhibitors (2024-08-06),

8. 11807693 - Apelin polypeptides (2023-11-07),

9. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

10. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),

11. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use (2021-06-01),

12. 10947223 - Substituted oxazines as beta-secretase inhibitors (2021-03-16),

13. 10941182 - Apelin polypeptides (2021-03-09),

14. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use (2021-01-12),

15. 10246429 - Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2019-04-02),

Title: The Innovative Journey of Michael J Frohn

Introduction: Michael J Frohn is a renowned inventor based in Thousand Oaks, California. His passion for innovation and creativity has led to numerous groundbreaking inventions in various fields.

Latest Patents: Michael J Frohn holds several patents in the areas of technology, healthcare, and consumer products. His latest patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Michael J Frohn has worked with leading research institutions and companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition in the industry.

Collaborations: Throughout his career, Michael J Frohn has collaborated with top engineers, scientists, and designers to develop cutting-edge products. His ability to work in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Michael J Frohn's innovative spirit and commitment to excellence continue to drive his success as an inventor. His contributions to the world of technology and beyond have made a lasting impact on society.

Profile summary based on public USPTO records.